GLTO
Galecto, Inc.
NASDAQ · Healthcare · Biotechnology · US
$21.58
−3.36%Latest reported
- Last report date
- May 12, 2026
- EPS actual
- -$0.62
- EPS estimate
- -$0.39
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -3537.8%
- Revenue beats (12Q)
- —
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of May 12, 2026